Aberdeen Group
TDOC icon

Aberdeen Group’s Teladoc Health TDOC Stock Holding History

Aberdeen Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-122,960
Closed -$3.12M – 930
2022
Q3 		$3.12M Buy
122,960
+75,600
+160% +$2.65M 0.01% 630
2022
Q2 		$1.63M Buy
47,360
+17,007
+56% +$722K 0.01% 736
2022
Q1 		$2.21M Buy
30,353
+8,631
+40% +$622K 0.01% 727
2021
Q4 		$2M Buy
21,722
+242
+1% +$28.9K ﹤0.01% 778
2021
Q3 		$2.71M Buy
21,480
+7,508
+54% +$1.09M 0.01% 742
2021
Q2 		$2.32M Buy
13,972
+885
+7% +$143K 0.01% 741
2021
Q1 		$2.38M Buy
13,087
+121
+0.9% +$28.1K 0.01% 745
2020
Q4 		$2.59M Buy
12,966
+4,870
+60% +$990K 0.01% 713
2020
Q3 		$1.77M Buy
8,096
+4,003
+98% +$848K ﹤0.01% 724
2020
Q2 		$781K Buy
+4,093
New +$717K ﹤0.01% 814

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Aberdeen Group's TDOC Position: Q4 2022 in Review

Aberdeen Group sold out of Teladoc Health (TDOC) in Q4 2022, closing a stake of 122,960 shares — an estimated $3.12M sold.

Aberdeen Group first reported a position in TDOC in Q2 2020 and held it in 10 quarters. The position peaked at $3.12M in Q3 2022. 443 funds tracked by Wall St. Rank hold TDOC as of Q4 2022.

  • Aberdeen Group reported no remaining Teladoc Health position as of Q4 2022 after selling out during the quarter.
  • Aberdeen Group sold 122,960 Teladoc Health shares in Q4 2022, an estimated $3.12M.
  • Aberdeen Group first reported a position in Teladoc Health in Q2 2020 and held it in 10 quarters.
  • Aberdeen Group's Teladoc Health position peaked at $3.12M in Q3 2022.
  • 443 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2022.

Based on Aberdeen Group's 13F filing for Q4 2022, filed 10 Feb 2023.